Oxford Cannabinoid Technologies Holdings PLC Sustainability Reports
The company operates as a pharmaceutical developer focused on creating next-generation, non-addictive prescription pain medications using cannabinoids. Its research targets severe, chronic pain conditions through proprietary cannabinoid derivatives, phytocannabinoids, and new chemical entities.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 2138005SRWT4998BCE35
3 reports from 2021 to 2024
